100% of moneycontrol users recommend buying Ind-Swift.
What's your call on Ind-Swift today?
Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||4261.50||1.90||4337.00||2965.00||72,696.30|
|Jun' 15||Mar' 15||Dec' 14||Sep' 14|
|No Mutual Funds Holding the share|
Alicon Castalloy Recommended on May 6th 2015
Recommended price 293.00 | Peak from reco 428.00 46.12%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ind-Swift is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 23.51 crore.
The company management includes Ashok Gupta - Ind. Non-Executive Director, A D Ahluwalia - Ind. Non-Executive Director, S R Mehta - Chairman, N R Munjal - Vice Chairman, Gopal Munjal - Managing Director & CEO, V R Mehta - Joint Managing Director, Rishav Mehta - Director, R S Bedi - Director, Himanshu Jain - Director, S P Sharma - Director, V K Arora - Additional Director, B M Padha - Nominee Director, Ashwani Vig - Independent Director.
It is listed on the BSE with a BSE Code of 524652 and the NSE with an NSE Code of INDSWFTLTD.
Its Registered office is at 781, Industrial Area - II , Chandigarh,Chandigarh - 160002.
Their Registrars are Alankit Assignment Ltd.